Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Also known as: Stage 3 Paranasal Sinus and Nasal Cavity Squamous Cell Carcinoma / Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12442 | Alvespimycin | 1 | Completed | 1 |
| DB00112 | Bevacizumab | 1 | Completed | 1 |
| DB00002 | Cetuximab | 1 | Completed | 1 |
| DB00002 | Cetuximab | 1 | Terminated | 1 |
| DB00515 | Cisplatin | 1 | Withdrawn | 1 |
| DB12304 | Entolimod | 1 | Withdrawn | 1 |
| DB00099 | Filgrastim | 1 | Completed | 1 |
| DB00544 | Fluorouracil | 1 | Completed | 1 |
| DB01005 | Hydroxyurea | 1 | Completed | 1 |
| DB16555 | Lactoferrin | 1 | Terminated | 1 |
| DB12303 | Motolimod | 1 | Completed | 1 |
| DB01268 | Sunitinib | 1 | Terminated | 1 |
| DB00112 | Bevacizumab | 1 / 2 | Completed | 1 |
| DB00002 | Cetuximab | 1 / 2 | Completed | 1 |
| DB01248 | Docetaxel | 1 / 2 | Completed | 1 |
| DB00530 | Erlotinib | 1 / 2 | Completed | 2 |
| DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
| DB02546 | Vorinostat | 1 / 2 | Completed | 1 |
| DB00112 | Bevacizumab | 2 | Completed | 1 |
| DB14235 | Bilberry | 2 | Withdrawn | 1 |
| DB00515 | Cisplatin | 2 | Terminated | 1 |
| DB14240 | Echinacea | 2 | Withdrawn | 1 |
| DB11805 | Saracatinib | 2 | Completed | 1 |